Revised regulations proposed for human subject research

Eighteen departments and agencies of the federal government have joined to propose revised regulations for scientific research involving human subjects.

Study sheds light on side effects of COX-2 drugs

A team of Vanderbilt University Medical Center scientists are closer to understanding why COX-2 inhibitors — drugs that relieve arthritis pain and inflammation without the gastrointestinal side effects of other painkillers — cause heart problems in some patients.

Now

Neimat: Emotional disturbance is an overlooked symptom of Parkinson’s

Despite benefiting from dramatic improvements in movement after deep brain stimulation surgery, patients with Parkinson’s disease can be inadequately served when physicians and researchers focus only on its motor manifestations, says a Vanderbilt neurosurgeon.

New faculty: Lisa Kachnic is pioneering advances in radiation therapy

New Department of Radiation Oncology Chair Lisa Kachnic wants to make Vanderbilt’s program one of the best in the country.

Biomarker for intestinal tumors

A new marker could be useful for diagnosing and treating neuroendocrine tumors of the small intestines.

A bundle, a dashboard and lasting pneumonia reduction

A “bundle” of electronically implemented care guidelines reduced intensive care unit patient complications related to mechanical ventilation.